IP Library › Granted Patent US 12,137,723
Granted Patent B2
US 12,137,723 · App. 17/187,987 · Granted Nov 12, 2024

Oral products with active ingredient combinations

Inventors: Anthony Richard Gerardi (Winston-Salem, NC); Ross Jay Oden (Winston-Salem, NC); Matthew Evan Lampe (Winston-Salem, NC); Kristen Ann Spielbauer (Kernersville, NC); Michael Andrew Zawadzki (Durham, NC)
Assignee: NICOVENTURES TRADING LIMITED
A24B13/00A24B15/301A24B15/303A24B15/306A24B15/308A24B15/32A24B15/385A24B15/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,137,723
App. No.
17/187,987
Granted
Nov 12, 2024
Kind
B2
Abstract

Compositions configured for oral use, the compositions including at least one active ingredient selected from caffeine, taurine, GABA, theanine, tryptophan, vitamin B6, vitamin B12, vitamin C, lemon balm extract, ginseng, citicoline, sunflower lecithin, or combinations thereof, are provided. The compositions include one or more fillers, including a sugar alcohol, and optionally, a lipid or binder. The compositions may be in chewable, tablet, or meltable forms.

Claims (51)

1. A composition in meltable form, configured for oral use, the composition comprising:

at least one active ingredient comprising caffeine and theanine, caffeine and taurine, or caffeine, theanine, and taurine;

a sugar alcohol; and

a lipid;

wherein the meltable form comprises the composition as a homogenous mixture.

2. The composition of claim 1 , wherein:

the sugar alcohol is present in an amount of from about 35 to about 55% by weight, based on the total weight of the composition; and

the lipid is present in an amount of from about 35 to about 50% by weight, based on the total weight of the composition.

3. The composition of claim 1 , wherein the lipid has a melting point of about 29° C. or above.

4. The composition of claim 1 , wherein the lipid has a melting point from about 36° ° C. to about 45° C.

5. The composition of claim 1 , wherein the lipid is an oil selected from the group consisting of palm oil, palm kernel oil, soybean oil, sunflower oil, cottonseed oil, coconut oil, and combinations thereof, wherein the oil may be hydrogenated, partially hydrogenated, or non-hydrogenated.

6. The composition of claim 1 , wherein the sugar alcohol is isomalt, erythritol, sorbitol, arabitol, ribitol, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol, or a combination thereof.

7. The composition of claim 1 , wherein the sugar alcohol is isomalt.

8. The composition of claim 1 , further comprising one or more B vitamins, vitamin C, ginseng, zinc, or a combination thereof.

9. The composition of claim 1 , further comprising citicoline or sunflower lecithin.

10. The composition of claim 1 , comprising:

caffeine in an amount of from about 2 to about 6% by weight, based on the total weight of the composition;

theanine in an amount of from about 2 to about 4% by weight, based on the total weight of the composition; and

vitamin B6 in an amount of from about 0.008% to about 0.07% by weight, based on the total weight of the composition.

11. The composition of claim 1 , comprising:

caffeine in an amount of from about 1.5 to about 5% by weight, based on the total weight of the composition;

taurine in an amount of from about 1.5 to about 6% by weight, based on the total weight of the composition; and

vitamin B6 in an amount of from about 0.008% to about 0.07% by weight, based on the total weight of the composition.

12. The composition of claim 1 , wherein at least a portion of the caffeine is present in encapsulated form.

13. A composition in meltable form, configured for oral use, the composition comprising:

theanine or taurine;

gamma-aminobutyric acid (GABA), magnesium, tryptophan, on or more B vitamins, ginseng, chamomile, lemon balm extract, or a combination thereof;

a sugar alcohol; and

a lipid;

wherein the meltable form comprises the composition as a homogenous mixture.

14. The composition of claim 13 , comprising:

theanine;

magnesium;

tryptophan; and

vitamin B6.

15. The composition of claim 13 , comprising:

theanine;

GABA; and

lemon balm extract.

16. The composition of claim 13 , wherein:

the sugar alcohol is present in an amount of from about 35 to about 55% by weight, based on the total weight of the composition; and

the lipid in an amount of from about 35 to about 50% by weight, based on the total weight of the composition.

17. The composition of claim 13 , wherein the lipid has a melting point of about 29° C. or above.

18. The composition of claim 13 , wherein the lipid has a melting point from about 36° ° C. to about 45° C.

19. The composition of claim 13 , wherein the lipid is an oil selected from the group consisting of palm oil, palm kernel oil, soybean oil, sunflower oil, cottonseed oil, coconut oil, and combinations thereof, wherein the oil may be hydrogenated, partially hydrogenated, or non-hydrogenated.

20. The composition of claim 13 , wherein the sugar alcohol is isomalt, erythritol, sorbitol, arabitol, ribitol, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol, or a combination thereof.

21. The composition of claim 13 , wherein the sugar alcohol is isomalt.

22. The composition of claim 1 , wherein the composition is free of nicotine.

23. The composition of claim 1 , wherein the composition is free of tobacco.

24. The composition of claim 13 , wherein the composition is free of nicotine.

25. The composition of claim 13 , wherein the composition is free of tobacco.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2021
From: GERARDI, ANTHONY RICHARD; ODEN, ROSS JAY; LAMPE, MATTHEW EVAN; SPIELBAUER, KRISTEN ANN; ZAWADZKI, MICHAEL ANDREW
To: NICOVENTURES TRADING LIMITED
Reel/Frame 055444/0681 →
Continuity (4)
Continuation PCTIB2020061472 · Dec 4, 2020
Continuation In Part 16706974 · Dec 9, 2019
Provisional Application 63036254 · Jun 8, 2020
Related Publication 20210177038A1 · Jun 17, 2021